Join

Compare · NUWE vs TMDX

NUWE vs TMDX

Side-by-side comparison of Nuwellis Inc. (NUWE) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both NUWE and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • TMDX is the larger of the two at $2.57B, about 6708.9x NUWE ($382,706).
  • Over the past year, NUWE is down 98.5% and TMDX is down 47.2% - TMDX leads by 51.3 points.
  • TMDX has been more active in the news (12 items in the past 4 weeks vs 10 for NUWE).
  • TMDX has more recent analyst coverage (18 ratings vs 1 for NUWE).
PerformanceNUWE-98.53%TMDX-47.21%
2025-06-10+0.00%2026-06-09
MetricNUWETMDX
Company
Nuwellis Inc.
TransMedics Group Inc.
Price
$0.14-1.23%
$74.36+4.47%
Market cap
$382,706
$2.57B
1M return
-87.03%
+9.69%
1Y return
-98.53%
-47.21%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2019
News (4w)
10
12
Recent ratings
1
18
NUWE

Nuwellis Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

TMDX

TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.